AKT1 and diabetes mellitus: Advanced glycation end product (AGE)-modified substrates, which play important roles in the pathogenesis of diabetes, lead to RPC dysfunction and death by reducing AKT signaling and can induce endothelial to mesenchymal transition [24, 25].